Filing Details
Vera Therapeutics, Inc. (NASDAQ:VERA) filed a Form 8-K with the Securities and Exchange Commission on July 09, 2026, disclosing a material event.
8k filedNASDAQ:VERA
Vera Therapeutics, Inc. (VERA) Reports Material Event to SEC
Filing Details Vera Therapeutics, Inc. (NASDAQ:VERA) filed a Form 8-K with the Securities and Exchange Commission on July 09, 2026, disclosing a material event. Market Context…
Market Context
Vera Therapeutics, Inc.'s stock currently trades at $42.45 with a market capitalization of $2.9B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Vera Therapeutics, Inc.'s stock.
All SEC filings for Vera Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View VERA Stock Page
Frequently Asked Questions
Where can I read VERA's SEC filings?
Browse all filings on our VERA SEC filings page.
What types of SEC filings does Vera Therapeutics, Inc. file?
Public companies like Vera Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.